Flt3L介导的瘤cDC1扩张通过在淋巴结中的干状CD8+ T细胞进行原始化来增强免疫疗法
Junyun Lai1,2, Cheok Weng Chan1,2, Jesse D Armitage1,2,3,4
1Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Nature immunology
|February 10, 2026
概括
扩张的树突细胞与Fms相关的氨酸激酶3联体 (Flt3L) 增强了抗瘤免疫力. 这种组合疗法增强了T细胞对抗癌症的反应,改善了治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 免疫检查点阻塞 (ICB) 重振T细胞对瘤的反应.
- T细胞分化状态极大地影响了ICB的疗效,分化较少的细胞表现出更大的增殖.
- 传统的1型树突细胞 (cDC1) 对于维持前体耗尽的T细胞 (TPEX) 至关重要.
研究的目的:
- 调查使用Flt3L扩展cDC1是否可以改善对ICB的反应.
- 阐明Flt3L治疗增强抗瘤免疫力的机制.
主要方法:
- 使用与Fms相关的氨酸激酶3连接体 (Flt3L) 进行治疗,以扩大树突细胞.
- 在瘤中分析T细胞群,特别是CD8+T细胞.
- 研究XCR1+树突细胞和淋巴结贩运的作用.
主要成果:
- 在瘤中,flt3L治疗扩大了CD62L+SLAMF6+CD8+T细胞.
- 这种扩张需要XCR1+树突细胞迁移到瘤排水淋巴结.
- 使用Flt3L和抗CTLA-4的组合疗法显著增强了治疗反应.
- 组合疗法导致了表达Il21r的CD8+T细胞子集,并促进了瘤内的基克隆T细胞扩张.
- 观察到的T细胞扩张取决于淋巴结的退出.
结论:
- 用Flt3L扩展cDC1s可以增强抗瘤免疫力并提高ICB的疗效.
- 通过flt3L介导的T细胞反应增强涉及树突细胞向淋巴结的贩运和随后的T细胞退出.
- 使用Flt3L和ICB的组合疗法代表了癌症治疗的有希望的策略.
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Detailed Structure and Function of Lymph Nodes
5.1K
Lymph nodes are bean-shaped structures that cluster along the lymphatic vessels in the inguinal, axillary, and cervical regions. Each node is divided into compartments by a capsule that extends trabeculae inward.
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
5.1K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.6K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K
Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K


